Early Tranexamic Acid (TXA) for Hip Fractures
This study is testing if giving tranexamic acid (TXA), a medicine that helps reduce bleeding, earlier to adults with hip fractures can decrease blood loss and the need for blood transfusions after surgery. You might be able to join if you are an adult (18 or older) with an acute hip fracture needing surgery. The study aims to see if giving TXA in the emergency department, in addition to during surgery, is better than only giving it during surgery. Researchers will measure how much blood you lose and if you need a blood transfusion up to two weeks after your operation. The current recruitment status is unclear.
- Study design
- This is an interventional study planning to enroll 170 participants, comparing different timings for giving tranexamic acid (TXA).
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Researchers will follow participants for up to two weeks after surgery to measure blood loss and transfusions.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Effect of Early Administration of TXA in Adult Hip Fractures
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- Postoperative Blood TransfusionUp to two weeks
Patient receives a blood transfusion during their postoperative stay in the hospital
- Overall Blood LossUp to two weeks
Calculate the difference in postoperative blood loss between groups